# GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir

> **NCT00883935** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GSK1349572
- **DRUG:** Atazanavir 300 mg
- **DRUG:** Atazanavir 400 mg
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00883935
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883935, "GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00883935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*